FOR PATIENTS · SOURCE READING
Treatment Option Overview
Source: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: June 5, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Continue within this section
Key Points →There are different types of treatment for children with acute myeloid leukemia and other myeloid malignancies. →Treatment is planned by a team of health care providers who are experts in treating childhood leukemia and other diseases of the blood. →The treatment of childhood AML and other myeloid malignancies usually has two phases. →Seven types of standard treatment may be used for childhood AML and other myeloid malignancies. →New types of treatment are being tested in clinical trials. →Treatment for childhood acute myeloid leukemia and other myeloid malignancies may cause side effects. →Patients may want to think about taking part in a clinical trial. →Patients can enter clinical trials before, during, or after starting their cancer treatment. →Follow-up tests may be needed. →
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle